[Neurophysiological studies with 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-on in animal experiments].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects*; D003864:Depression, Chemical; D004357:Drug Synergism; D004558:Electric Stimulation; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects*; D008027:Light; D010076:Oxazepam / Q000494:pharmacology* / Q000627:therapeutic use; D010433:Pentylenetetrazole; D012154:Reticular Formation / Q000187:drug effects*; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy; D012890:Sleep / Q000187:drug effects
D000927:Anticonvulsants; D010076:Oxazepam; D010433:Pentylenetetrazole
Neurophysiologische Untersuchungen mit 7-Chlor-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-on im Tierexperiment.